Table 2.
Compound | (Disease) Model | Effect on BKCa | Effects in the Model | Potential Mechanisms | References |
---|---|---|---|---|---|
Knocking down KCNMB1 | Chronic hypoxia-induced PH mouse model employing Kcnmb1−/− mouse | Inhibition | Increased pulmonary vascular response to acute and chronic hypoxia and increased RV pressure in vivo Increased focal complex expression in PASMCs in vitro |
Downregulates BKCa channels (mRNA, protein and function) in PASMCs | [77] |
Knocking down HIF-1α or KCNMB1 | Subacute hypoxia in hPASMCs | Inhibits upregulation of KCNMB1 in response to hypoxia | Potentiated the hypoxic-mediated increase in [Ca2+]i in vitro Strongly vasodilated PA rings ex vivo |
Downregulates BKCa channels (mRNA, protein and function) in PASMCs | [79] |
Overexpression or inhibition of miR-29b | Healthy and IPAH PASMCs | Inhibition or activation, respectively | Decreased BKCa channel currents and downregulated KCNMB1 in normal PASMCs in vitro Increased BKCa channel activity and upregulated KCNMB1 in IPAH-PASMC in vitro |
Downregulation or activation of the channel in PASMCs | [80] |
Upregulated KCNMB1 | IPF fibroblasts | Activation | Increased BKCa channel activity in vitro | Upregulated BKCa mRNA and protein in IPF fibroblasts | [83] |